Publications found:
60,074
Sort by:
Zimmer: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
... strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Facilities and Employees Section 3: Technological Know-how Section 4: Product Portfolio Section 5: Marketing Tactics Section 6: R&D Programs Section 7: Strategic Direction Contains 30 ...
July 2014
30 pages
Wright Medical: Organization, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
A strategic assessment of Wright Medical, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
July 2014
30 pages
Stryker: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
... goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Facilities and Employees Section 3: Technological Know-how Section 4: Product Portfolio Section 5: Marketing Tactics Section 6: R&D Expenditures and Major Programs Section 7: ...
July 2014
35 pages
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 27,600.00
... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...
July 2014
1200 pages
2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 15,760.00
... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...
July 2014
820 pages
2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 7,840.00
... be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... growing demand for malignancy assays and the rapid market expansion. US Market Overview Five-year test volume and sales projections ...
July 2014
620 pages
Smith & Nephew: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
A strategic assessment of Smith & Nephew, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
July 2014
37 pages
DePuy Synthes: Organization, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
... , capabilities, goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Technological Know-how Section 3: Product Portfolio Section 4: Marketing Tactics Section 5: Research & Development Section 6: Strategic Direction Contains 46 ...
July 2014
46 pages
ConMed: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
... strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Facilities and Employees Section 3: Technological Know-how Section 4: Product Portfolio Section 5: Marketing Tactics Section 6: R&D Programs Section 7: Strategic Direction Contains ...
July 2014
25 pages
Biomet: Organization, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
... , goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Technological Know-how Section 3: Product Portfolio Section 4: Marketing Tactics Section 5: R&D Expenditures and Major Programs Section 6: Strategic Direction Contains 35 ...
July 2014
35 pages
Aesculap: Organization, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
... , capabilities, goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Technological Know-how Section 3: Product Portfolio Section 4: Marketing Tactics Section 5: R&D Programs Section 6: Strategic Direction Contains 22 pages
July 2014
22 pages
Flavor, Fragrances, Aroma Chemicals, Essential Oils: Formula for Success - Superior Customer Insights and Exclusive Manufacturing Know-How to Support Customer Demands
US$ 3,080.00
... regions (USA, Europe, Asia). Analysis of key product categories (flavors, fragrances, aroma chemicals, essential oils). Five-year sales forecasts by product category ... , and social trends with potentially significant impact on the flavor and fragrance industry during the next five years, including discussion ...
June 2014
154 pages
2014 Clinical Chemistry and Immunodiagnostic Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations
US$ 9,200.00
... (test volumes, sales forecasts, supplier shares) $7,500. 2014 Clinical Chemistry and Immunodiagnostics Testing in US Hospitals, Commercial Laboratories and Point-of-Care ... suppliers. Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
June 2014
635 pages
New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape
US$ 6,800.00
New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, ...
June 2014
450 pages
New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape
US$ 6,800.00
New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups ... hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...
June 2014
279 pages
New Frontiers in Point-of-Care/POC Infectious Disease Testing:Business Challenges, Emerging Technologies, Competitive Landscape
US$ 6,800.00
New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC infections disease testing market, including its dynamics, size, growth, regulatory ...
June 2014
835 pages
New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape
US$ 13,200.00
New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of theten POC market segments, including their dynamics, size, growth, regulatory requirements, ...
May 2014
1172 pages
New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape
US$ 10,000.00
New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, ...
May 2014
973 pages
New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape
US$ 10,000.00
New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the physician office market segment, including dynamics, size, growth, regulatory requirements, technological ...
May 2014
970 pages
New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape
US$ 10,000.00
New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, ...
May 2014
973 pages
New Frontiers in the French Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape
US$ 4,880.00
... $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in the French Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, ... the nextfive years. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes, ...
May 2014
542 pages
